LARA MARKS, Visiting Research Fellow, History of Biomedical Sciences, University of Cambridge ANKUR MUTRJA, Group Leader, Global Health (Infectious Diseases), University of Cambridge WITH the world’s attention focused on combating COVID-19, it is easy to forget the other significant threat to public health and the global economy – the rapid rise of antimicrobial resistance (AMR). Yet the problem has not disappeared. Indeed, the pandemic is probably accelerating it. Predicted to cause 10 million deaths a year by 2050 if left unchecked, AMR occurs where microorganisms, such as bacteria, viruses, fungi and parasites, develop resistance to antimicrobial drugs (such as antibiotics,…